Transdermal reverse iontophoresis of valproate: A noninvasive method for therapeutic drug monitoring

Pharmaceutical Research

Volumn 20, Issue 9, 2003, Pages 1508-1513

  Delgado Charro, M Begoña ^a,b   Guy, Richard H ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Ctr Interuniv Rech d'Enseignement   (France)

Author keywords

Iontophoresis; Reverse iontophoresis; Therapeutic drug monitoring; Transdermal extraction; Valproate

Indexed keywords

GLUTAMIC ACID; VALPROIC ACID;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MONITORING; DRUG TISSUE LEVEL; ELECTRODE; IN VITRO STUDY; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; SKIN; STANDARDIZATION; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALIBRATION; DRUG MONITORING; FEASIBILITY STUDIES; GLUTAMIC ACID; IONTOPHORESIS; SKIN; SKIN ABSORPTION; SWINE; TIME FACTORS; VALPROIC ACID;

EID: 0141566579     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025730815971     Document Type: Article

References (28)

1. R. E. Kauffman and G. L. Kearns. Pharmacokinetics studies in paediatric patients. Clinical end ethical considerations. Clin. Pharmacokinet. 23:10-29 (1992).
2. R. K. Drobitch and C. K. Svenson. Therapeutic drug monitoring in saliva. An update. Clin. Pharmacokinet. 23:365-379 (1992).
3. B. Bailey, J. Klein, and G. Koren. Noninvasive methods for drug measurement in pediatrics. Pediatr. Clin. North Am. 44:15-26 (1997).
4. C. K. Svenson. Ethical considerations in the conduct of clinical pharmacokinetic studies. Clin. Pharmacokinet. 17:217-222 (1989).
5. J. T. Gilman and P. Gal. Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier. Clin. Pharmacokinet. 23:1-9 (1992).
6. P. D. Walson. Therapeutic drug monitoring in special populations. Clin. Chem. 44:415-419 (1998).
7. M. G. Murphy, C. C. Peck, D. P. Conner, K. Zamani, G. B. Merenstein, and D. Rodden. Transcutaneous theophylline collection in preterm infants. Clin. Pharmacol. Ther. 47:427-434 (1990).
8. C. C. Peck, K. Lee, and C. E. Becker. Continuous transepidermal drug collection: Basis for use in assessing drug intake and pharmacokinetics. J. Pharmacokinet. Biopharm. 9:41-58 (1981).
9. P. Kintz, R. Brenneisn, P. Bundeli, and P. Mangin. Sweat testing for heroin and metabolites in a heroin maintenance program. Clin. Chem. 43:736-739 (1997).
10. P. Kintz, A. Tracqui, C. Jamey, and P. Mangin. Detection of codeine and phenobarbital in sweat collected with a sweat patch. J. Anal. Toxicol. 20:197-201 (1996).
11. M. B. Delgado-Charro and R. H. Guy. Transdermal iontophoresis for drug delivery and non-invasive monitoring. STP Pharma. Sci. 11:403-414 (2001).
12. M. J. Pikal. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliver. Rev. 9:201-237 (1992).
13. P. Glikfeld, R. S. Hinz, and R. H. Guy. Noninvasive sampling of biological fluids by iontophoresis. Pharm. Res. 6:988-990 (1989).
14. G. Rao, P. Glikfeld, and R. H. Guy. Reverse iontophoresis: Development of a noninvasive approach for glucose monitoring. Pharm. Res. 10:1751-1755 (1993).
15. G. Rao, R. H. Guy, P. Glikfeld, W. R. LaCourse, L. Leung, J. Tamada, R. O. Ports, and N. Azimi. Reverse iontophoresis: Noninvasive glucose monitoring in vivo in humans, Pharm. Res. 12:1869-1873 (1995)
16. J. A. Tamada, S. Garg, L. Jovanovic, K. R. Pitzer, S. Fermi, and R. O. Ports. Noninvasive glucose monitoring. Comprehensive clinical results. JAMA 282:1839-1844 (1999).
17. V. Merino, A. López, D. Hochstrasser, and R. H. Guy. Noninvasive sampling of phenylalanine by reverse iontophoresis. J. Control. Release 61: 65-69 (1999).
18. N. Sekkat, A. Naik, Y. N. Kalia, P. Glikfeld, and R. H. Guy. Reverse iontophoretic monitoring in premature neonates: feasibility and potential. J. Control. Release 81:83-89 (2002).
19. A. Warner, M. Privitera, and D. Bates. Standards of laboratory practice: antiepileptic drug monitoring. Clin. Chem. 44:1085-1095 (1998).
20. P. Glikfeld, C. Cullander, R. S. Hinz, and R. H. Guy. A new system for in vitro studies of iontophoresis. Pharm. Res. 5:443-446 (1988).
21. P. G. Green, R. S. Hinz, C. Cullander, G. Yamane, and R. H. Guy. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8:1113-1120 (1991).
22. D. Marro, Y. N. Kalia, M. B. Delgado-Charro, and R. H. Guy. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm. Res. 18:1701-1708 (2001).
23. J. B. Phipps and J. R. Gyory. Transdermal ion migration. Adv. Drug Deliver. Rev. 9:137-176 (1992).
24. J. H. Zar. Biostatistical Analysis. Prentice Hall, Englewood Cliffs, New Jersey, 1984.
25. M. Lindberger, T. Tomson, L. Wallstedt, and L. Ståhle. Distribution of valproate to subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma in humans: A microdialysis study. Epilepsia 42:256-261 (2001).
26. N. G. Turner, L. Ferry, M. Price, C. Cullander, and R. H. Guy. Iontophoresis of poly-L-lysines: the role of molecular weight? Pharm. Res. 14:1322-1331 (1997).
27. G. B. Kasting and J. C. Keister. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J. Control. Release 8:195-210 (1989).
28. M. J. Pikal and S. Shah. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm. Res. 7:222-231 (1990).